ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q3 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,581,946 | -15.3% | 1,702,781 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $36,117,677 | -8.8% | 1,775,697 | -2.4% | 0.00% | 0.0% |
| Q1 2023 | $39,584,182 | -28.1% | 1,819,126 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $55,066,379 | +23.7% | 1,776,908 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $44,518,000 | +26.7% | 1,745,108 | +0.8% | 0.00% | 0.0% |
| Q2 2022 | $35,129,000 | -22.3% | 1,730,470 | -5.3% | 0.00% | 0.0% |
| Q1 2022 | $45,208,000 | -29.4% | 1,827,314 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $64,032,000 | +29.1% | 1,842,683 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $49,609,000 | +1.5% | 1,829,230 | -2.9% | 0.00% | 0.0% |
| Q2 2021 | $48,855,000 | -2.5% | 1,884,141 | -18.9% | 0.00% | 0.0% |
| Q1 2021 | $50,089,000 | +4.9% | 2,324,259 | +4.7% | 0.00% | 0.0% |
| Q4 2020 | $47,737,000 | +56.8% | 2,220,321 | +7.6% | 0.00% | 0.0% |
| Q3 2020 | $30,445,000 | -39.6% | 2,064,077 | -8.5% | 0.00% | -50.0% |
| Q2 2020 | $50,390,000 | +52.0% | 2,255,580 | -3.9% | 0.00% | +100.0% |
| Q1 2020 | $33,152,000 | -7.0% | 2,346,214 | +6.9% | 0.00% | 0.0% |
| Q4 2019 | $35,664,000 | -53.9% | 2,194,661 | -0.8% | 0.00% | -66.7% |
| Q3 2019 | $77,442,000 | -30.9% | 2,213,233 | +11.5% | 0.00% | -25.0% |
| Q2 2019 | $112,001,000 | -20.1% | 1,985,144 | +3.4% | 0.00% | -33.3% |
| Q1 2019 | $140,228,000 | +16.4% | 1,919,617 | +1.6% | 0.01% | +20.0% |
| Q4 2018 | $120,513,000 | -34.8% | 1,889,201 | +2.0% | 0.01% | -28.6% |
| Q3 2018 | $184,767,000 | +68.5% | 1,851,930 | +20.0% | 0.01% | +40.0% |
| Q2 2018 | $109,645,000 | -16.0% | 1,543,413 | +23.0% | 0.01% | -16.7% |
| Q1 2018 | $130,580,000 | +42.4% | 1,254,621 | +37.8% | 0.01% | +50.0% |
| Q4 2017 | $91,713,000 | +516.0% | 910,570 | +113.8% | 0.00% | +300.0% |
| Q3 2017 | $14,888,000 | +201.9% | 425,986 | +106.8% | 0.00% | – |
| Q2 2017 | $4,931,000 | +5.7% | 206,031 | +22.6% | 0.00% | – |
| Q1 2017 | $4,665,000 | – | 168,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |